Goldman Sachs, Morgan Stanley have earnings momentum and are reporting this week. There are others

Ahead of third-quarter earnings, analysts’ consensus EPS estimates for Goldman Sachs rose more than 300% over three months and 59% over six months; its $13.07 September-quarter EPS estimate and average price target imply 18% upside over 12 months. Morgan Stanley’s EPS estimate climbed 144% over three months and 73% over six, with a $2.94 estimate and about 15% implied upside. Goldman reports Tuesday and Morgan Stanley Wednesday; investors will also watch Morgan Stanley’s M&A and lending outlook amid higher bond yields.

Analysis

The key risk is treating estimate momentum as durable earnings power. Goldman’s unusually large revision is especially vulnerable to a one-off interpretation: verify whether the SpaceX transaction is reflected in the September quarter, how much of the revised EPS is transaction-driven, and whether analysts have also raised forward-year estimates. If revisions are concentrated in a single quarter, the setup is vulnerable to post-print estimate givebacks despite an EPS beat. The reported Palmer Square bid and CEO-succession discussion add strategic and governance uncertainty, but neither is yet a dependable earnings catalyst.

For Morgan Stanley, the more useful test is whether institutional-securities strength is broadening beyond trading into advisory, while wealth-management flows and margins remain resilient. Higher bond yields are two-sided: they can pressure dealmaking, startup funding and lending demand, while the effect on bank net interest income depends on deposit pricing and balance-sheet mix. The market should distinguish those channels rather than trade a simple “higher yields help banks” narrative.

Near term (this week), earnings guidance and revenue mix matter more than consensus EPS beats. Over 1–3 months, revisions after the reports and evidence of a sustained advisory pipeline are the catalysts. Over 6–18 months, any shift toward recurring fee income would matter more than episodic underwriting or trading. The contrarian risk is that the screen’s price-target upside and rising estimates look compelling but may already embed strong execution; absent confirmation in forward guidance, there may be no broad bank-sector trade.

Key Decisions for Investors

• Avoid buying GS solely on the estimate-revision screen ahead of Tuesday’s report. Reassess after the print; require disclosure that the EPS change is not mainly a one-quarter transaction effect and that forward-year earnings or guidance also improved. A beat with unchanged forward outlook would falsify the bullish read.
• For MS, wait for Wednesday’s report and favor a conditional long only if advisory activity is improving alongside resilient wealth-management flows, rather than trading on trading revenue alone. Reconsider if management cites weaker deal pipelines, funding conditions or client activity.
• Keep broad bank exposure neutral into the clustered reports; BAC, C, JPM and WFC offer read-through on deposit costs, credit quality and loan demand. A meaningful upward revision to credit-loss expectations or weaker net interest income guidance would argue against adding XLF exposure.
• Monitor Treasury yields and post-earnings estimate revisions over the next 1–3 months. If yields rise while advisory guidance and loan demand weaken, reduce financials exposure; if forward estimates broaden beyond isolated transaction or trading strength, a sector long becomes more credible.